...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

Cabel can you please show me something that says Biogen's PII trial was successful. If it's out there I have missed it. I know their share price went on a wild ride when they presented the results that said they were able to slow the progression of Alzheimers's but never did find anything that said the trial was successful.

BIIB got a $17 billion dollar boost in MC for slowing the progression of Alzheimer's by .23%? What do you think we will get by showing an improvement in cognitive Function by 1%, 5% or even 10%?

It would be great if RVX could get the trading haulted on Friday morning to get the attention of the market to look at those results that were presented the evening before at CTAD.

Friday could be a very exciting day, money problems or not.

tada

Share
New Message
Please login to post a reply